In particular, the poor prognosis of cancers with high GJB2-positive signatures, including pancreatic cancer, suggests that GJB2-positive CAFs play an important role in fibrosis and clinical outcomes. This evidence concerns the gene GJB2 and pancreatic neoplasm.